oncology

5 Successful Phase III Oncology Trials in Q1
BioSpace
Tue, 04/9/24 - 11:50 am
oncology
clinical trials
Bristol Myers Squibb
Opdivo
Yervoy
liver cancer
Pfizer
DLBCL
Adcetris
Asieris
HSIL
APL-1702
cervical cancer
Novocure
non-small cell lung cancer
Roche
Genentech
Tecentriq
esophageal squamous cell carcinoma
Merck KGaA signs $1.4B biobuck deal with Caris to expand ADC pipeline
Fierce Biotech
Thu, 04/4/24 - 11:17 am
Merck KGaA
oncology
antibody-drug conjugates
Caris Life Sciences
Teva, forging ahead with new strategy, inks biosimilar deal with Spain's mAbxience
Fierce Pharma
Thu, 04/4/24 - 11:16 am
Teva Pharmaceutical
Spain
mAbxience
oncology
biosimilars
Merck, Others Look to Immunotherapy Combos as Next Frontier in Oncology
BioSpace
Mon, 03/25/24 - 11:32 am
Merck
Keytruda
immunotherapy
oncology
cancer
Eliem cuts in on Tango, proposing acquisition after strategic review
Fierce Biotech
Tue, 03/19/24 - 11:51 am
Eliem Therapeutics
Tango Therapeutics
M&A
oncology
Biotheus, Hansoh Expand Partnership in $694M ADC Deal
BioSpace
Sun, 03/17/24 - 09:20 pm
Biotheus
Hansoh
antibody-drug conjugate
oncology
inflammatory diseases
Bayer, AI-Focused Aignostics Partner to Find New Oncology Targets
BioSpace
Sun, 03/17/24 - 09:19 pm
Bayer
artificial intelligence
drug development
oncology
Aignostics
Alkermes and Jazz: Two Different Approaches to Neuroscience, Oncology Portfolios
BioSpace
Tue, 03/12/24 - 11:02 am
Alkermes
Jazz Pharma
Neuroscience
oncology
IRA Drives Pfizer’s Decision to Focus on Biologics, Not Small Molecules
BioSpace
Wed, 03/6/24 - 11:17 am
Pfizer
oncology
Inflation Reduction Act
biologics
FogPharma pulls in $145M to support cancer drug research
BioPharma Dive
Mon, 03/4/24 - 11:10 am
FogPharma
funding
cancer
oncology
ADC Market Will Remain Hot in Oncology, Reaching $30B by 2028: Report
BioSpace
Fri, 03/1/24 - 11:52 am
oncology
cancer
antibody-drug conjugate
Merck
AbbVie
Pfizer
AstraZeneca
Pfizer fleshes out oncology strategy, targeting 8 blockbuster cancer drugs by 2030
Fierce Pharma
Thu, 02/29/24 - 07:05 pm
Pfizer
oncology
Pharma CEOs
Albert Bourla
antibody-drug conjugate
Why is pharma going gaga for radiopharmaceuticals?
Pharmaphorum
Tue, 02/27/24 - 11:19 am
radiopharmaceuticals
oncology
Novartis
Eli Lilly
Bristol Myers Squibb
6 first-half 2024 oncology data readouts to watch
BioSpace
Mon, 02/26/24 - 11:20 am
oncology
clinical trials
Daiichi Sankyo
AstraZeneca
Enhertu
metastatic breast cancer
Gilead Sciences
Trodelvy
bladder cancer
GSK
Zejula
Jemperli
ovarian cancer
Roche
tiragolumab
Tecentriq
non-small cell lung cancer
Cue Biopharma
CUE-101
head and neck cancer
Elicio Therapeutics
ELI-002
solid tumors
Was Pfizer’s “Here’s to Science” commercial during the Super Bowl a winning play or a fumble?
Stat
Mon, 02/12/24 - 11:09 pm
Pfizer
pharma advertising
Super Bowl
oncology
cancer
Pfizer launches oncology ad campaign at Super Bowl LVIII
Medical Marketing and Media
Sun, 02/11/24 - 03:55 pm
Pfizer
oncology
Super Bowl
pharma advertising
Jazz buys KRAS inhibitors from Redx in $880m deal
Pharmaphorum
Wed, 02/7/24 - 11:18 am
Jazz Pharma
Redx Pharma
KRAS inhibitors
oncology
Gilead will not buy Tizona after paying $300M for the right to do so
Fierce Biotech
Wed, 02/7/24 - 11:17 am
Gilead Sciences
Tizona Therapeutics
M&A
oncology
Top 40 Best-Selling Oncology Drugs in 2023 by 2022 Data
Xtalks
Mon, 02/5/24 - 10:17 am
oncology
cancer
Keytruda
Revlimid
Opdivo
Imbruvica
Darzalex
Merck
Bristol Myers Squibb
AbbVie
Janssen
CG Oncology prices larger-than-expected $380M IPO in hopeful sign for biotech
BioPharma Dive
Wed, 01/24/24 - 11:36 pm
CG Oncology
IPOs
cancer
oncology

Pages